Clinical Trial Update: Safety and Efficacy of Eltrombopag at Escalated Doses [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of escalated doses of eltrombopag in immune thrombocytopenia, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Immune Thrombocytopenia, Platelet Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-06-11